Nina Nandy

Nina Nandy
University of New Mexico | UNM · gastroenterology and hepatology



How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
Dr. Nina Nandy received her BA in Microbiology from Cornell University where she was on the Dean's List and also a recipient of the Paul Vandemark award for excellence in microbiology. Nina continued her degree at New York University and received an MS in Molecular Biology. After receiving her MS, she attended medical school at the Boston University School of Medicine where she graduated Cum Laude. Her internship was completed in Internal Medicine at Beth Israel Deaconess medical center in Boston, MA. She completed her residency at the University of Connecticut. Nina completed her fellowship in Gastroenterology and Hepatology at the University of New Mexico. She is currently a Gastroenterologist at Presbyterian Medical Group in Albuquerque, NM.
Additional affiliations
August 2014 - present
University of New Mexico
  • Fellow
February 2017 - December 2019
Harvard Business School Online
Field of study
  • Certificate in Financial Accounting
August 2012 - May 2014
University of Connecticut
Field of study
  • Internal Medicine
August 2009 - May 2010
Harvard Medical School
Field of study
  • Intern, Internal Medicine


Publications (11)
Full-text available
Background Inflammatory bowel disease (IBD) is characterised by acute intestinal mucosal inflammation with chronic inflammatory features. Various degrees of mucosal eosinophilia are present along with the typical acute (neutrophil-predominant) inflammation. The effect of intestinal eosinophils on IBD outcomes remains unclear. Methods This is a ret...
Full-text available
A 32-year-old man presented to the emergency department with difficulty swallowing oral secretions and the feeling that food was stuck in his throat after he ate a pizza roll. The patient reported that similar episodes had occurred previously, but in each instance the feeling resolved spontaneously, and he did not seek medical care. At the time of...
Full-text available
Development of a second primary malignancy after an index esophageal cancer is a rare event, primarily due to short survival of patients with esophageal cancer. However, the number of long-term esophageal cancer survivors has been increasing due to advances in early detection and therapy. We report herein a case of pancreatic adenocarcinoma that de...
Background: Development of a second primary malignancy (SPM) after an index esophageal cancer is fairly rare, primarily due to decreased survival in patients with esophageal cancer. However, with advances in early detection and therapy, the number of long-term survivors is increasing, as is the incidence of SPMs in this population. Scope: We rev...
Introduction: Carcinoid tumors are uncommon neoplasms that offer unique therapeutic challenges to practicing physicians. Several chemotherapy combinations and IFN-α have been used for the treatment of unresectable carcinoid tumors over the last decades, but they have shown variable clinical results. Given the heterogeneity of these tumors, there i...
"Chemobrain" is the phenomenon of cognitive decline some patients may experience after chemotherapy. Current research indicates the cognitive domains that may be most impacted by chemotherapeutic agents are visual and verbal memory, attention, and psychomotor functioning. These cognitive deficits can have an effect on a patient's ability to make in...
CNS synapses are produced rapidly upon pre- and post-synaptic recruitment. However, their composition is known to change during development and we reasoned that this may be reflected in the gross biochemical properties of synapses. We found synaptic structure in adult cortical synaptosomes to be resistant to digestion with trypsin in the presence a...


Cited By


Project (1)
Archived project